Calidi Biotherapeutics, Inc. · AMEX:CLDI

Armistice Capital, LLC reported a 9.99% stake in Calidi Biotherapeutics, Inc. (Schedule 13G)

Event Mar 31, 2026 · Filed May 15, 2026

Armistice Capital, LLC reported a 9.99% stake in Calidi Biotherapeutics, Inc., 1,111,732 shares, as a passive investor on Mar 31, 2026. Filed May 15, 2026 (Schedule 13G).

Stake
9.99%
Shares
1,111,732
Intent
Passive
What changed
Crossed above 5%
Filed together
2 holders

The filing in full

HolderStakeShares
Armistice Capital, LLC9.99%1,111,732
Steven Boyd9.99%1,111,732

Source

View original at SEC

Related